Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatment

In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding discontinua...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chau, Sek Hung (VerfasserIn) , Sluiter, Reinier Luuk (VerfasserIn) , Hugtenburg, Jacqueline Geertruida (VerfasserIn) , Wensing, Michel (VerfasserIn) , Kievit, Wietske (VerfasserIn) , Teichert, Martina (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2020
In: Drugs & aging
Year: 2019, Jahrgang: 37, Heft: 1, Pages: 67-74
ISSN:1179-1969
DOI:10.1007/s40266-019-00713-5
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40266-019-00713-5
Volltext
Verfasserangaben:Sek Hung Chau, Reinier Luuk Sluiter, Jacqueline Geertruida Hugtenburg, Michel Wensing, Wietske Kievit, Martina Teichert
Beschreibung
Zusammenfassung:In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding discontinuation of a PPI after cessation of NSAID or LDASA treatment.
Beschreibung:Published online: 27 September 2019
Gesehen am 01.04.2020
Beschreibung:Online Resource
ISSN:1179-1969
DOI:10.1007/s40266-019-00713-5